Postmenopausal estrogen administration suppresses muscle sympathetic nerve activity

Area of Science:

• Cardiovascular Physiology
• Neuroendocrinology
• Autonomic Nervous System Research

Background:

• Sympathetic nervous system activity exhibits gender-specific differences, with lower muscle vascular bed activity in women compared to men.
• This difference diminishes after menopause, suggesting a role for estrogen in regulating autonomic function.

Purpose of the Study:

• To investigate the hypothesis that estrogen influences autonomic nervous system activity in postmenopausal women.
• To determine if estrogen replacement therapy can modulate muscle sympathetic activity (MSA) in this population.

Main Methods:

• A randomized, double-blind, crossover study involving 11 healthy postmenopausal women.
• Participants received transdermal estradiol (E2) or placebo for two days, with MSA, blood pressure, and heart rate measured at rest and during sympathoexcitatory maneuvers.
• Serum E2 levels were assessed to confirm physiological relevance.

Main Results:

• Transdermal estradiol administration increased serum E2 to physiological levels and significantly reduced MSA.
• No significant changes in blood pressure or heart rate were observed.
• The physiological sympathetic response to maneuvers like apnea and cold pressor test remained unchanged.

Conclusions:

• Elevating estrogen levels in postmenopausal women suppresses muscle sympathetic activity (MSA).
• This sympathoinhibitory effect of estrogen may be mediated by central autonomic centers.
• Estrogen's influence on sympathetic outflow could explain gender differences and contribute to cardiovascular benefits of hormone replacement therapy.